Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellysis has developed the S-Patch line of wearable ECG monitors that provide continuous cardiac rhythm monitoring with real-time AI-powered analytics. The devices have received regulatory approvals including FDA clearance for the US market. Clinical collaborations include published results on atrial fibrillation prediction with Samsung Medical Center. The company’s solutions are used globally and have demonstrated high accuracy in ECG waveform capture and arrhythmia detection[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellysis.